Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus)

Infection and Immunity

Volumn 66, Issue 3, 1998, Pages 1063-1069

  Nasarre, C ^a,c   Krahenbuhl, J L ^b   Klei, T R ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUGIA PAHANGI; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GERBIL; GRANULOMATOUS INFLAMMATION; IMMUNIZATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MICROFILARIA; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SPLEEN CELL; TOXOPLASMA GONDII;

EID: 0031887899     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.3.1063-1069.1998     Document Type: Article

References (61)

1. Adams, L. B., J. B. J. Hibbs, R. R. Taintor, and J. L. Krahenbuhl. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725-2729.
2. Agarrwal, B. B., W. J. Kohr, P. E. Hass, B. Moffat, S. A. Spencer, W. J. Henzel, T. S. Bringman, G. E. Nedwin, D. V. Goeddel, and R. N. Harkins. 1985. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260:2345-2354.
3. Alfes, C., J. Steele, J. Stanford, and G. Rook. 1985. The effect of lymphokines on the ability of macrophages to protect mycobacteria from a bactericidal antibiotic. Tubercle 1:1-7.
4. Civil, R. H., K. S. Warren, and A. A. F. Mahmoud. 1978. Conditions for Bacille Calmette-Guerin-induced resistance to infection with Schistosoma mansoni in mice. J. Infect. Dis. 137:550-555.
5. Denis, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55:682-684.
6. De Waal-Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. De Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
7. De Waal-Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. De Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
8. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407-2412.
9. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. F. Crowle. 1986. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal hut enhances replication of macrophage-associated mycohacteria. Infect. Immun. 50:1-8.
10. Drapier, J. C., and J. B. J. Hibbs. 1988. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cell. J. Immunol. 140:2829-2838.
11. Ellner, J. J., and P. J. Spagnuold. 1979. Suppression of antigen and mitogen induced human T-lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J. Immunol. 123:2689-2695.
12. Green, S. J., T.-Y. Chen, R. M. Crawford, C. N. Nacy, D. C. Morrison, and M. S. Meltzer. 1992. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73kD LPS receptor. J. Immunol. 149:2069-2075.
13. Green, S. J., R. M. Crawford, M. S. Meltzer, J. B. J. Hibbs, and C. A. Nacy. 1990. Leishmania provide a second signal for nitric oxide production by interferon-gamma treated macrophages by stimulation of TNF-alpha. J. Immunol. 145:4290-4297.
14. Green, S. J., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-284.
15. Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli, and J. A. Hamilton. 1989. Potential anti-inflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, prostaglandin E2. Proc. Natl. Acad. Sci. USA 86:3803-3807.
16. Hibbs, J. B., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation of nitrite. Science 235:473-476.
17. Ho, J. L., S. H. He, M. J. Rios, and E. A. Wick. 1992. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J. Infect. Dis. 165:344-351.
18. Hoover, D. L., D. A. Nacy, and M. S. Meltzer. 1985. Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma. Cell. Immunol. 94:500-511.
19. James, S. L., and J. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208-4212.
20. James, S. L., J. K. Lazdins, M. S. Meltzer, and A. Sher. 1982. Macrophages as effector cells of protective immunity in murine schistosomiasis. I. Activation of peritoneal macrophages during natural infection. Cell. Immunol. 67: 255-266.
21. James, S. L., A. Sher, J. K. Lazdins, and M. S. Meltzer. 1982. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection. J. Immunol. 128:1535-1540.
22. Jeffers, G. W., T. R. Klei, and F. M. Enright. 1984. Activation of gerbil (Meriones unguiculatus) macrophages by the filarial parasite Brugia pahangi. Infect. Immun. 43:43-48.
23. Jeffers, G. W., T. R. Klei, F. M. Enright, and G. W. Henk. 1987. The granulomatous inflammatory response in gerbils, Meriones unguiculatus, to Brugia pahangi: an ultrastructural and histochemical comparison of reaction in the lymphatics and peritoneal cavity. J. Parasitol. 73:1220-1233.
24. Jeska, E. L. 1969. Mouse peritoneal exudate reactions to parasitic worms. I. Cell adhesion reactions. Immunology 16:761-771.
25. King, C. L., V. Kumaraswami, R. W. Poindexter, S. Kumari, K. Jayaraman, D. W. Ailing, E. A. Ottesen, and T. B. Nutman. 1992. Immunological tolerance in lymphatic filariasis: diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J. Clin. Invest. 89:1403-1410.
26. King, C. L., S. Mahanty, V. Kumaraswami, J. S. Abrams, J. Raganathan, K. Jayaraman, E. A. Ottesen, and T. B. Nutman. 1993. Cytokine control of parasite specific anergy in human lymphatic filariasis: preferential induction of a regulatory Th2 lymphocyte subset. J. Clin. Invest. 92:1667-1673.
27. Klei, T. R., F. M. Enright, D. P. Blanchard, and S. A. Uhl. 1981. Specific hypo-responsive granulomatous tissue reactions in Brugia pahangi-infected jirds. Acta Trop. 38:267-276.
28. Klei, T. R., F. M. Enright, D. P. Blanchard, and S. A. Uhl. 1982. Effects of presensitization on the development of lymphatic lesions in Brugia pahangi-infected jirds. Am. J. Trop. Med. Hyg. 31:280-291.
29. Klei, T. R., C. S. McVay, V. A. Dennis, S. U. Coleman, F. M. Enright, and H. A. Casey. 1990. Brugia pahangi: effects of duration of infection and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity, and immune responses in jirds (Meriones unguiculatus). Exp. Parasitol. 71: 393-405.
30. Krahenbuhl, J. L., and L. B. Adams. 1994. The role of the macrophage in resistance to the leprosy bacillus. Immunol. Ser. 60:281-302.
31. Lainson, R. 1955. Toxoplasmosis in England. II. Variation factors in the pathocenesis of Toxoplasma infections: the sudden increase in virulence of a strain after passage in multimammate rats and canaries. Ann. Trop. Med. Parasitol. 49:397-416.
32. Lammie, P. J., and S. P. Katz. 1983. Immunoregulation in experimental filariasis. II. Responses to parasite and nonparasite antigens in jirds infected with Brugia phangi. J. Immunol. 130:1386-1389.
33. Langermans. J. A., M. E. Van der Hulst, P. H. Nibberling, P. S. Hiemstra, L. Fransen, and R. Van Furth. 1992. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148: 568-574.
34. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J. Immunol. 143:3020-3024.
35. Lichtenberg, F. 1957. The early phase of endemic bancroftian filariasis in the male. Pathological study. J. Mt. Sinai Hosp. 26:983-1000.
36. Liu, L. X., J. E. Buhlmann, and P. F. Weller. 1992. Release of prostaglandin E2 by microtilariae of Wuchereria bancrofti and Brugia malayi. Am. J. Trop. Med. Hyg. 46:520-523.
37. Mahmoud, A. A. F., A. S. Peters, R. H. Civil, and J. S. Remington. 1979. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum activated macrophages. J. Immunol. 122:1655-1662.
38. Maizels, R. M., E. Sartono, A. Kurniawan, F. Partono, M. E. Selkirk, and M. Yazdanbakhsh. 1995. T-cell activation and the balance of antibody isotypes in human lymphatic filariasis. Parasitol. Today 11:50-56.
39. Murray, H. W., and D. M. Cartelli. 1983. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. J. Clin. Invest. 72: 32-44.
40. Nacy, C. A., A. H. Fortier, M. S. Meltzer, N. A. Buchmeier, and R. D. Schreiber. 1985. Macrophage activation to kill Leishmania major activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon gamma and non-interferon lymphokines. J. Immunol. 135:3505-3511.
41. Nasarre, C., S. U. Coleman, U. R. Rao, and T. R. Klei. 1997. Differential induction and regulation of inflammatory responses by life cycle stages of Brugia pahangi. Exp. Parasitol. 87:20-29.
42. Nasarre, C., U. R. Rao, S. U. Coleman, and T. R. Klei. 1997. Effect of gamma radiation on Brugia L3 development in vivo and the kinetics of granulomatous inflammation induced by these parasites. J. Parasitol. 83:1119-1123.
43. Nathan, C., and J. B. J. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial immunity. Curr. Opin. Immunol. 3:65-70.
44. Nelson, D. S., D. Subrahmanyam, Y. V. B. C. Rao, and K. Mehta. 1976. Cellular morphology in pleural exudate of albino rats infected with Litomosoides carinii. Trans. R. Soc. Trop. Med. Hyg. 70:254-255.
45. Nutman, T. B., V. Kumaraswami, and E. A. Ottesen. 1987. Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J. Clin. Invest. 79:1516-1523.
46. Ottesen, E. A. 1980. Immunopathology of lymphatic filariasis in man. Springer Semin. Immunopathol. 2:373-385.
47. Ottesen, E. A., P. F. Weller, and L. Heck. 1977. Specific cellular immune unresponsiveness in human filariasis. Immunology 33:413-421.
48. Petit, T. A., S. U. Coleman, K. L. Jones, F. M. Enright, and T. R. Klei. 1993. Brugia pahangi: effects of protective resistance on lymphatic lesions and granulomatous inflammation in infected gerbils (Meriones unguiculatus). Exp. Parasitol. 77:395-404.
49. Piessens, W. F., P. B. McGreevy, P. W. Piessens, M. McGreevy, J. Koiman, H. S. Sarsoso, and D. T. Dennis. 1980. Immune responses in human infections with Brugia malayi. Specific cellular unresponsiveness to filarial antigens. J. Clin. Invest. 65:172-179.
50. Rajan, T. V., P. Porte, J. A. Yates, L. Keefer, and L. D. ,Schultz. 1996. Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect. Immun. 64:3351-3353.
51. Reiner, N. E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15:374-381.
52. Rook, G. A. W., J. Steel, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 19: 333-338.
53. Ruco, L. P., and M. S. Meltzer. 1977. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by PPD in BCG-immune mice. Cell. Immunol. 32:203-215.
54. Sibley, D. L., and J. L. Krahenbuhl. 1988. Defective activation of granuloma macrophages from Mycobacterium leprae-infected nude mice. J. Leukocyte Biol. 43:60-66.
55. Sibley, L. D., L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl. 1991. Tumor necrosis factor-alpha triggers antitoxoplasma activity of IFN-gamma-primed macrophages. J. Immunol. 147:2340-2345.
56. Silva, J. S., P. J. Morrissey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1991. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-174.
57. Snyder, D. S., D. I. Beller, and E. R. Unanue. 1982. Prostaglandin-modulated macrophage Ia expression. Nature 299:163-165.
58. Stadecker, M. J. 1994. The shrinking schistosomal egg granuloma: how accessory cells control T cell-mediated pathology. Exp. Parasitol. 79:198-201.
59. Taffet, S. M., and S. W. Russell. 1981. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E. J. Immunol. 126:424-127.
60. Toba, H., J. Crawford, and J. Ellner. 1989. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of human gamma interferon. Infect. Immun. 57:239-244.
61. Wilson, C. B., V. Tsai, and J. S. Remington. 1980. Failure to trigger the oxidative metabolic burst by normal macrophages. J. Exp. Med. 151:328-346.